Stocklytics Platform
Asset logo for symbol PYXS
Pyxis Oncology
PYXS47
$3.40arrow_drop_up0.29%$0.01
Penny Stock
Asset logo for symbol PYXS
PYXS47

$3.40

arrow_drop_up0.29%

AI Deep-Learning Forecast (PYXS)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Pyxis Oncology (PYXS) Stocklytics Forecast

In recent years, Pyxis Oncology, Inc. (PYXS) has seen significant growth and has become an exciting player in the biotechnology industry. With a focus on developing innovative cancer therapies, the company has attracted attention from investors and analysts alike. As a result, there has been much speculation about the future stock price of PYXS, with many interested in making price predictions and forecasts.
While it is impossible to predict the future stock price of any company with certainty, analysts and AI algorithms have attempted to provide some insights into PYXS's potential performance. Using machine learning algorithms and advanced statistical models, these predictions take into account various factors such as historical data, market trends, and the company's pipeline of drugs under development.
add Pyxis Oncology to watchlist

Keep an eye on Pyxis Oncology

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Pyxis Oncology (PYXS) stock?

Analysts have set a target price of $11 for Pyxis Oncology (PYXS), based on forecasts from 13 analysts. The predicted price range extends from a high of $25 to a low of $4. This represents a potential increase of up to 634.21% and a decrease of 17.47% from the current price of $3.4. These forecasts are as of 2021 Nov 02.
help

What are the analyst ratings for Pyxis Oncology (PYXS) stock?

Currently, there are no analyst ratings available for Pyxis Oncology (PYXS), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for Pyxis Oncology (PYXS) stock?

At present, there is no AI or machine-learning-based price prediction available for Pyxis Oncology (PYXS) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media